Nivolumab vs Osimertinib

## Nivolumab vs Osimertinib: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Osimertinib**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

**Osimertinib**: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Osimertinib — 48 hours.

## Chemical Properties

**Molecular Formula**: Nivolumab — N/A; Osimertinib — C28H33N7O2.

**Molecular Weight**: Nivolumab — N/A; Osimertinib — 499.6050 g/mol.

**Type**: Nivolumab — Antibody; Osimertinib — Small molecule.